Patents by Inventor Peter John Sharratt

Peter John Sharratt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperidine derivatives having tachykinin antagonist activity
    Patent number: 6020346
    Abstract: The present invention relates to piperidine derivatives of formula (I): ##STR1## wherein the substituents R.sup.1, R.sup.3, R.sup.4 and R.sup.5 are as defined in the specification and claims, and the substituent R.sup.2 is ##STR2## The pharmaceutically acceptable salts and solvates of these piperidine derivatives are also described. The invention also relates to processes for the preparation of the piperidine derivatives, and to their use in the treatment of conditions mediated by tachykinins.
    Type: Grant
    Filed: July 8, 1997
    Date of Patent: February 1, 2000
    Assignee: Glaxo Wellcome Inc.
    Inventors: Duncan Robert Armour, Gerard Martin Paul Giblin, Andrew Michael Kenneth Pennell, Peter John Sharratt
  • 3-benzylamino-2-phenylpiperidines as neurokinin antagonists
    Patent number: 5919803
    Abstract: The invention relates to piperidine derivatives of formula (I) ##STR1## wherein R.sup.1 is a C.sub.2-4 alkoxy group; R.sup.2 is ##STR2## R.sup.3 is a hydrogen or halogen atom; R.sup.4 and R.sup.5 may each independently represent a hydrogen or halogen atom, or a C.sub.1-4 alkyl, C.sub.1-4 alkoxy or trifluoromethyl group;and pharmaceutically acceptable derivatives thereof, to processes for their preparation, and their use in the treatment of conditions mediated by tachykinins.
    Type: Grant
    Filed: August 20, 1997
    Date of Patent: July 6, 1999
    Assignee: Glaxo Group Limited
    Inventors: Gerard Martin Paul Giblin, Peter John Sharratt